interferon α-2b

BIOLOGICAL2 trials

Sponsors

Merck Sharp & Dohme LLC, Zhejiang Provincial People's Hospital

Conditions

MelanomaTumour

Unknown Phase

Efficacy and Safety of High-dose Interferon Alfa-2b (Intron A®) for the Adjuvant Treatment of Malignant Melanoma (Study P04083)

CompletedNCT00749684

Merck Sharp & Dohme LLCMelanoma

Start: 1996-12-31End: 2009-09-30Updated: 2015-10-19

Evaluate the Efficacy and Safety of Interferon-α Combined With ATO in the Treatment of Arsenic-resistant APL

RecruitingNCT06450145

Zhejiang Provincial People's HospitalTumour

Start: 2024-05-01End: 2025-12-31Target: 15Updated: 2024-06-10